Related Experiment Video
Updated: Jun 11, 2026
07:20
Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
Harnessing structure-activity relationship to engineer a cisplatin nanoparticle for enhanced antitumor efficacy
Abhimanyu S Paraskar1, Shivani Soni, Kenneth T Chin
1Department of Medicine, Brigham and Women's Hospital, Cambridge, MA 02139, USA.
Summary
Researchers engineered a novel nanoparticle delivering cisplatin chemotherapy. This nanoplatinate reduces kidney toxicity and enhances anti-cancer efficacy in preclinical models, offering a promising alternative for cancer treatment.
Area of Science:
- Biotechnology
- Nanotechnology
- Oncology
Background:
- Cisplatin is a vital chemotherapy drug but causes severe nephrotoxicity, limiting its clinical use.
- Developing safer and more effective platinum-based chemotherapy is crucial for cancer treatment.
Purpose of the Study:
- To rationally engineer a novel nanoplatinate with improved efficacy and reduced toxicity.
- To investigate the self-assembly, drug release, cellular uptake, and therapeutic potential of the engineered nanoplatinate.
Main Methods:
- Synthesized glucosamine-functionalized polyisobutylene-maleic acid-platinum (Pt) nanoparticles.
- Evaluated nanoparticle self-assembly and pH-dependent cisplatin release.
- Assessed in vitro cytotoxicity and in vivo antitumor efficacy in breast, lung, and ovarian cancer models.
- Quantified platinum biodistribution in kidneys using inductively coupled plasma spectroscopy.
Main Results:
- The nanoplatinate self-assembled and released cisplatin in a pH-dependent manner.
- Nanoparticles showed comparable in vitro cytotoxicity to cisplatin and superior efficacy to carboplatin.
- Demonstrated enhanced antitumor efficacy and tumor regression in preclinical cancer models.
- Significantly reduced platinum accumulation in kidneys, indicating lower nephrotoxicity.
Conclusions:
- The engineered nanoplatinate offers a promising strategy to improve cisplatin chemotherapy by enhancing efficacy and reducing severe side effects.
- This nanotechnology approach, combined with structure-activity relationship insights, could significantly impact global cancer treatment.
